Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
24.97
+0.30 (1.22%)
Jan 8, 2026, 4:00 PM EST - Market closed
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $2.64 billion as of January 9, 2026. Its market cap has decreased by -9.30% in one year.
Market Cap
2.64B
Enterprise Value
2.08B
1-Year Change
-9.30%
Ranking
Category
Stock Price
$24.97
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $2.64B, an increase of 247.34%. That is a compound annual growth rate of 29.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 2.64B | 0.62% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | 761.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.45B |
| Johnson & Johnson | 495.04B |
| AbbVie | 395.22B |
| UnitedHealth Group | 314.29B |
| AstraZeneca | 297.23B |
| Novartis AG | 273.11B |
| Merck & Co. | 271.71B |
| Novo Nordisk | 254.60B |